Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vi-CRM197 Vaccine for Typhoid in Children and Infants
NCT01437267Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2011
- Primary completion
- Aug 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Vi-CRM197 in typhoid fever, sponsored by Novartis. Started Oct 2011; status: completed.
02
Drugs
Vi-CRM197
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT01437267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437267.